Pharmaceutical Control of the
Human Microbiome

Symberix Selected to Present at Start-Up Stadium at International BIO Conference

June 2017

Symberix was selected from a competitive international applicant pool to be one of only 40 companies to present at Start-Up Stadium at the BIO Conference, the world’s largest biotechnology event. The Start-Up Stadium event provides emerging companies with access to members of the investment community, venture philanthropy groups, and BIO attendees.  Symberix was the only company selected from North Carolina to participate in the event occurring from June 20-22.

For additional information, visit: http://convention.bio.org/startup/

 


Back to News